Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: A new presentation of primary extranodal marginal zone B-cell lymphoma of MALT

Annals of Oncology

Volumn 21, Issue 6, 2009, Pages 1189-1195

  Paulli, M ^a   Arcaini, L ^a   Lucioni, M ^a   Boveri, E ^a   Capello, D ^b   Passamonti, F ^a   Merli, M ^a   Rattotti, S ^a   Rossi, D ^b   Riboni, R ^a   Berti, E ^c   Magrini, U ^a   Bruno, R ^a   Gaidano, G ^b   Lazzarino, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Hepatitis C virus; IGH rearrangement; MALT; Marginal zone lymphoma; Subcutaneous tissue

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; INTERFERON; PREDNISONE; RIBAVIRIN; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER INFILTRATION; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE REARRANGEMENT; GERMINAL CENTER; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; SEROLOGY; SOMATIC MUTATION; SUBCUTANEOUS NODULE; SUBCUTANEOUS TISSUE TUMOR; TREATMENT RESPONSE; CHROMOSOME 11; CHROMOSOME 18; COMPLICATION; DIFFERENTIAL DIAGNOSIS; GENE TRANSLOCATION; GENETICS; HEPACIVIRUS; LIPOMA; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; MIDDLE AGED; NEOPLASMS, CONNECTIVE TISSUE; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SUBCUTANEOUS TISSUE;

AGED; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 18; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HEPACIVIRUS; HEPATITIS C; HUMANS; LIPOMA; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, CONNECTIVE TISSUE; RETROSPECTIVE STUDIES; SUBCUTANEOUS TISSUE; TRANSLOCATION, GENETIC;

EID: 77951630180     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp454     Document Type: Article

References (41)

1. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000; 96(2): 410-419.
2. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 2007; 38: 1293-1304.
3. Roggero E, Zucca E, Mainetti C et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000; 31: 263-268.
4. Ferreri AJ, Dolcetti R, Du MQ et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 2008; 19: 835-846.
5. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
6. Arcaini L, Burcheri S, Rossi A et al. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 2007; 18: 346-350.
7. Zuckerman E, Zuckerman T, Levine AM et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428.
8. Ambrosetti A, Zanotti R, Pattaro C et al. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol 2004; 126: 43-49.
9. Arcaini L, Paulli M, Boveri E et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 2004; 100: 107-115.
10. Negri E, Little D, Boiocchi M et al. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 2004; 111: 1-8.
11. Hermine O, Lefrere F, Bronowicki JP et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94.
12. Vallisa D, Bernuzzi P, Arcaini L et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol 2005; 23: 468-473.
13. Mele A, Pulsoni A, Bianco E et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 996-999.
14. de Sanjose S, Benavente Y, Vajdic CM et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6: 451-458.
15. Michaelis S, Kazakov DV, Schmid M et al. Hepatitis C and G viruses in B-cell lymphomas of the skin. J Cutan Pathol 2003; 30: 369-372.
16. Boveri E, Arcaini L, Merli M et al. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients. Ann Oncol 2009; 20: 129-136.
17. Swerdlow SH, Campo E, Harris NL et al. World Health Organization Classification of Tumours of Haematopoietic and Lymhoid Tissues. Lyon: IARC Press 2008.
18. Capello D, Cerri M, Muti G et al. Molecular histogenesis of posttransplantation lymphoproliferative disorders. Blood 2003; 102: 3775-3785.
19. Lasota J, Franssila K, Kao CH, Miettinen M. Molecular diagnosis of mantle cell lymphoma in paraffin-embedded tissue. Mod Pathol 1996; 9: 361-366.
20. Liu J, Johnson RM, Traweek ST. Rearrangement of the bcl-2 gene in follicular lymphoma. Detection by PCR in both fresh and fixed tissue samples. Diagn Mol Pathol 1993; 2: 241-247.
21. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006; 107: 3034-3044.
22. Saadoun D, Suarez F, Lefrere F et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 105: 74-76.
23. Viguier M, Rivet J, Agbalika F et al. B-cell lymphomas involving the skin associated with hepatitis C virus infection. Int J Dermatol 2002; 41: 577-582.
24. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002; 55: 4-13.
25. Travis W, Banks P, Reiman H. Primary extranodal soft tissue lymphoma of the extremities. Am J Surg Pathol 1987; 11: 359-366.
26. Bailey EM, Ferry JA, Harris NL et al. Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa associated lymphoid tissue type) of skin and subcutaneous tissue. Am J Surg Pathol 1996; 20: 1011-1023.
27. Ferreri AJ, Viale E, Guidoboni M et al. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann Oncol 2006; 17: 769-772.
28. Willemze R, Jansen PM, Cerroni L et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood 2008; 111: 838-845.
29. De Re V, De Vita S, Marzotto A et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000; 96: 3578-3584.
30. Marasca R, Vaccari P, Luppi M et al. Immunoglobulin gene mutations and frequently use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 2001; 159: 253-261.
31. Chan CH, Hadlock KG, Foung SKH, Levy S. VH1-69 gene is preferentially used by hepatitis C virus-associated B-cell lymphomas and by normal B-cells responding to the E2 viral antigen. Blood 2001; 97: 1023-1026.
32. Küppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341: 1520-1529.
33. Chadburn A, Cesarman E, Knowles DM. Molecular pathology of posttransplantation lymphoproliferative disorders. Semin Diagn Pathol 1997; 14: 15-26.
34. Weng WK, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma 2003; 44: 1113-1120.
35. Charles ED, Green RM, Marukian S et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood 2008; 111: 1344-1356.
36. Dierlamm J, Baens M, Wlodarska I et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601-3609.
37. Willis TG, Jadayel DM, Du MQ et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT type B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35-45.
38. Streubel B, Lamprecht A, Dierlamm J et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101: 2335-2339.
39. Streubel B, Vinatzer U, Lamprecht A et al. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005; 19: 652-658.
40. Streubel B, Simonitsch-Klupp I, Mullauer L et al. Variable frequencies of MALT lymphomas at different sites. Leukemia 2004; 18: 1722-1726.
41. Liu H, Ye H, Ruskone-Fourmestraux A et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286-1294.